Gene Therapy for Rare Neurological Disorders

Area of Science:

• Neurology
• Genetics
• Biotechnology

Background:

• Rare diseases, often single-gene neurologic disorders, collectively impact millions globally.
• Recombinant adeno-associated virus vectors have revolutionized treatment possibilities.
• Existing gene therapies have shown success in specific inherited conditions.

Purpose of the Study:

• To highlight the advancements in gene therapy for rare neurologic diseases.
• To discuss the potential of emerging gene editing technologies.

Main Methods:

• Review of recent breakthroughs in gene therapy development.
• Analysis of FDA-approved treatments and ongoing clinical trials.

Main Results:

• Successful FDA-approved gene therapies exist for conditions like inherited retinal dystrophy and spinal muscular atrophy.
• Numerous other gene therapies for rare neurologic disorders are in various developmental stages.

Conclusions:

• Gene therapy represents a significant therapeutic advance for rare neurologic diseases.
• Gene editing technologies are poised to expand treatment options for a wider patient population.